CLINICAL_TRIALS
trial_result
· 2024-09-24
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus [Phase 2]
Summary
Phase 2 trial evaluating the efficacy and safety of topical ruxolitinib cream for lichen sclerosus has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Lichen Sclerosus | Phase 2 | Status: COMPLETED | Results posted: 2024-09-24